A Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast Cancer

NCT02054338 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1004

Enrollment

INDUSTRY

Sponsor class

Stopped Study was stopped before progressive disease or death of alive subjects.

Conditions

Advanced Breast Cancer

Interventions

DRUG: Vinflunine+Gemcitabine
DRUG: Paclitaxel+Gemcitabine

Sponsor

Pierre Fabre Medicament